메뉴 건너뛰기




Volumn 104, Issue 1, 2009, Pages 107-114

Regulation of growth factors in hormone- and drug-resistant prostate cancer cells by synergistic combination of docetaxel and octreotide

Author keywords

Docetaxel; DU 145; Growth factors; Octreotide; PC 3

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CASPASE 3; CASPASE 7; DOCETAXEL; OCTREOTIDE; PLATELET DERIVED GROWTH FACTOR AB; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA;

EID: 67650480102     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08340.x     Document Type: Article
Times cited : (18)

References (25)
  • 3
    • 4744366279 scopus 로고    scopus 로고
    • Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
    • Tannock IF, Berry WR, Horti J et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004 351 : 1502 12
    • (2004) N Engl J Med , vol.351 , pp. 1502-12
    • Tannock, I.F.1    Berry, W.R.2    Horti, J.3
  • 4
    • 0031035693 scopus 로고    scopus 로고
    • Bcl2 is the guardian of microtubule integrity
    • Haldar S, Basu A, Croce CM. Bcl2 is the guardian of microtubule integrity. Cancer Res 1997 57 : 229 33
    • (1997) Cancer Res , vol.57 , pp. 229-33
    • Haldar, S.1    Basu, A.2    Croce, C.M.3
  • 5
    • 2942625492 scopus 로고    scopus 로고
    • Preclinical pharmacology of the taxanes: Implications of the differences
    • Gligorov J, Lotz JP. Preclinical pharmacology of the taxanes: implications of the differences. Oncologist 2004 9 (Suppl. 2 3 8 (Pubitemid 38747838)
    • (2004) Oncologist , vol.9 , Issue.SUPPL. 2 , pp. 3-8
    • Gligorov, J.1    Lotz, J.P.2
  • 6
    • 33845650679 scopus 로고    scopus 로고
    • A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9
    • Sun LC, Luo J, Mackey LV, Fuselier JA, Coy DH. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9. Cancer Lett 2007 246 : 157 66
    • (2007) Cancer Lett , vol.246 , pp. 157-66
    • Sun, L.C.1    Luo, J.2    MacKey, L.V.3    Fuselier, J.A.4    Coy, D.H.5
  • 7
    • 0035985284 scopus 로고    scopus 로고
    • The clinical role of somatostatin analogues as antineoplastic agents: Much ado about nothing?
    • Hejna M, Schmidinger M, Raderer M. The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing? Ann Oncol 2002 13 : 653 68
    • (2002) Ann Oncol , vol.13 , pp. 653-68
    • Hejna, M.1    Schmidinger, M.2    Raderer, M.3
  • 8
    • 0033561724 scopus 로고    scopus 로고
    • Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238
    • Plonowski A, Schally AV, Nagy A, Sun B, Szepeshazi K. Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238. Cancer Res 1999 59 : 1947 53
    • (1999) Cancer Res , vol.59 , pp. 1947-53
    • Plonowski, A.1    Schally, A.V.2    Nagy, A.3    Sun, B.4    Szepeshazi, K.5
  • 9
    • 0036482860 scopus 로고    scopus 로고
    • Effective treatment of experimental DU-145 prostate cancers with targeted cytotoxic somatostatin analog AN-238
    • Plonowski A, Schally AV, Nagy A, Sun B, Halmos G. Effective treatment of experimental DU-145 prostate cancers with targeted cytotoxic somatostatin analog AN-238. Int J Oncol 2002 20 : 397 402
    • (2002) Int J Oncol , vol.20 , pp. 397-402
    • Plonowski, A.1    Schally, A.V.2    Nagy, A.3    Sun, B.4    Halmos, G.5
  • 10
    • 34447329624 scopus 로고    scopus 로고
    • Somatostatin effects on the proteome of the LNCaP cell-line
    • Liu Z, Bengtsson S, Krogh M et al. Somatostatin effects on the proteome of the LNCaP cell-line. Int J Oncol 2007 30 : 1173 9
    • (2007) Int J Oncol , vol.30 , pp. 1173-9
    • Liu, Z.1    Bengtsson, S.2    Krogh, M.3
  • 11
    • 0027364440 scopus 로고
    • Direct inhibitory effect of somatostatin on the growth of the human prostatic cancer cell line LNCaP: Possible mechanism of action
    • Brevini TA, Bianchi R, Motta M. Direct inhibitory effect of somatostatin on the growth of the human prostatic cancer cell line LNCaP: possible mechanism of action. J Clin Endocrinol Metab 1993 77 : 626 31
    • (1993) J Clin Endocrinol Metab , vol.77 , pp. 626-31
    • Brevini, T.A.1    Bianchi, R.2    Motta, M.3
  • 12
    • 33644804885 scopus 로고    scopus 로고
    • Profiling of signaling molecules in four different human prostate carcinoma cell lines before and after induction of apoptosis
    • Skjoth IH, Issinger OG. Profiling of signaling molecules in four different human prostate carcinoma cell lines before and after induction of apoptosis. Int J Oncol 2006 28 : 217 29
    • (2006) Int J Oncol , vol.28 , pp. 217-29
    • Skjoth, I.H.1    Issinger, O.G.2
  • 13
    • 12344272623 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells
    • DOI 10.1002/pros.20140
    • Fronsdal K, Saatcioglu F. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells. Prostate 2005 62 : 299 306 (Pubitemid 40129069)
    • (2005) Prostate , vol.62 , Issue.3 , pp. 299-306
    • Fronsdal, K.1    Saatcioglu, F.2
  • 14
    • 0026604939 scopus 로고
    • Basic fibroblast growth factor in human prostate cancer cells
    • Nakamoto T, Chang C, Li A. Basic fibroblast growth factor in human prostate cancer cells. Cancer Res 1992 52 : 571 7
    • (1992) Cancer Res , vol.52 , pp. 571-7
    • Nakamoto, T.1    Chang, C.2    Li, A.3
  • 15
    • 0021118703 scopus 로고
    • Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
    • Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984 22 : 27 55
    • (1984) Adv Enzyme Regul , vol.22 , pp. 27-55
    • Chou, T.C.1    Talalay, P.2
  • 16
    • 48749111500 scopus 로고    scopus 로고
    • The combination of docetaxel and the somatostatin analogue lanreotide on androgen-independent docetaxel-resistant prostate cancer: Experimental data
    • Lo NC, Maffi M, Fischel JL, Formento P, Milano G, Merlano M. The combination of docetaxel and the somatostatin analogue lanreotide on androgen-independent docetaxel-resistant prostate cancer: experimental data. BJU Int 2008 102 : 622 7
    • (2008) BJU Int , vol.102 , pp. 622-7
    • Lo, N.C.1    Maffi, M.2    Fischel, J.L.3    Formento, P.4    Milano, G.5    Merlano, M.6
  • 17
    • 0025996354 scopus 로고
    • Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones
    • Schuurmans AL, Bolt J, Veldscholte J, Mulder E. Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. J Steroid Biochem Mol Biol 1991 40 : 193 7
    • (1991) J Steroid Biochem Mol Biol , vol.40 , pp. 193-7
    • Schuurmans, A.L.1    Bolt, J.2    Veldscholte, J.3    Mulder, E.4
  • 18
    • 0027730415 scopus 로고
    • Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines
    • Ching KZ, Ramsey E, Pettigrew N, D'Cunha R, Jason M, Dodd JG. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol Cell Biochem 1993 126 : 151 8
    • (1993) Mol Cell Biochem , vol.126 , pp. 151-8
    • Ching, K.Z.1    Ramsey, E.2    Pettigrew, N.3    D'Cunha, R.4    Jason, M.5    Dodd, J.G.6
  • 19
    • 39449103998 scopus 로고    scopus 로고
    • TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells
    • Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Prostate 2008 68 : 287 95
    • (2008) Prostate , vol.68 , pp. 287-95
    • Zhu, M.L.1    Partin, J.V.2    Bruckheimer, E.M.3    Strup, S.E.4    Kyprianou, N.5
  • 20
    • 35648999534 scopus 로고    scopus 로고
    • Recent advances in cancer stem/progenitor cell research: Therapeutic implications for overcoming resistance to the most aggressive cancers: Stem Cells Review Series
    • DOI 10.1111/j.1582-4934.2007.00088.x
    • Mimeault M, Hauke R, Mehta PP, Batra SK. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med 2007 11 : 981 1011 (Pubitemid 350037046)
    • (2007) Journal of Cellular and Molecular Medicine , vol.11 , Issue.5 , pp. 981-1011
    • Mimeault, M.1    Hauke, R.2    Mehta, P.P.3    Batra, S.K.4
  • 21
    • 0033304745 scopus 로고    scopus 로고
    • Transforming growth factor-beta1-induced proliferation of the prostate cancer cell line, TSU-Pr1: The role of platelet-derived growth factor
    • Sintich SM, Lamm ML, Sensibar JA, Lee C. Transforming growth factor-beta1-induced proliferation of the prostate cancer cell line, TSU-Pr1: the role of platelet-derived growth factor. Endocrinology 1999 140 : 3411 5
    • (1999) Endocrinology , vol.140 , pp. 3411-5
    • Sintich, S.M.1    Lamm, M.L.2    Sensibar, J.A.3    Lee, C.4
  • 22
    • 11244303506 scopus 로고    scopus 로고
    • Expression of tyrosine kinases in human malignancies as potential targets for kinase-specific inhibitors
    • Singer CF, Hudelist G, Lamm W, Mueller R, Czerwenka K, Kubista E. Expression of tyrosine kinases in human malignancies as potential targets for kinase-specific inhibitors. Endocr Relat Cancer 2004 11 : 861 9
    • (2004) Endocr Relat Cancer , vol.11 , pp. 861-9
    • Singer, C.F.1    Hudelist, G.2    Lamm, W.3    Mueller, R.4    Czerwenka, K.5    Kubista, E.6
  • 23
    • 0033152596 scopus 로고    scopus 로고
    • Transforming growth factor-beta in benign and malignant prostate
    • Lee C, Sintich SM, Mathews EP et al. Transforming growth factor-beta in benign and malignant prostate. Prostate 1999 39 : 285 90
    • (1999) Prostate , vol.39 , pp. 285-90
    • Lee, C.1    Sintich, S.M.2    Mathews, E.P.3
  • 24


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.